Group name
Focal treatment (Total)
BCR
15 (25)
p-value
0.51
remark
Recurrence, n (%)
Continence
57 (98)
p-value
0.303
remark
Erectile dysfunction, n (%)
Complications or other prognosis
13 (21)
p-value
0.269
remark
Need for further ADT, n (%)
Follow Up Time
/